198 results
8-K
EX-3.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
19 Apr 24
Amendments to Articles of Incorporation or Bylaws
4:06pm
of office, will not become a party to (1) any agreement, arrangement or understanding with, and has not given and will not give any commitment … Commitment”) or (2) any Voting Commitment that could limit or interfere with such proposed nominee’s ability to comply, if elected as a Director
8-K
t2lmg2ma0 9e4
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
8-K
EX-10.1
9zpxaugs8l37
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
425
EX-99.1
bft0xl y1g
21 Jun 22
Business combination disclosure
8:00am
8-K
EX-99.1
fkfah6gbj yus0w6ayv
21 Jun 22
Regulation FD Disclosure
6:19am
425
7nzfi6f
24 Mar 22
Business combination disclosure
9:09am
8-K
EX-2.4
j2uygpl897h1n
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.2
lky55t2
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.1
n35sgecj qiz5
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
425
EX-99.2
o729b12 ocy0
23 Mar 22
Business combination disclosure
5:29pm
8-K
EX-99.2
nob2x18xi ml5rc9b1m
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm